{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:53:20Z","timestamp":1766415200686,"version":"3.48.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.annpat.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T11:26:34Z","timestamp":1760354794000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Actualit\u00e9s dans le grading des m\u00e9ningiomes\u00a0: l\u2019exp\u00e9rience de l\u2019H\u00f4pital Sainte-Anne"],"prefix":"10.1016","volume":"46","author":[{"given":"Arnault","family":"Tauzi\u00e8de-Espariat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"M\u00e9tais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Pucelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Mandoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeina","family":"Dababou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Carnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Berthaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le\u00efla","family":"Brissez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Saffroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Lebre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euphrasie","family":"Servant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Varlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2025.09.004_bib0230","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021\u00a0WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0235","series-title":"WHO classification of tumours of the central nervous system","first-page":"94","author":"Louis","year":"2016"},{"key":"10.1016\/j.annpat.2025.09.004_bib0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007\u00a0WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/jocn.2000.0829","article-title":"The 2000\u00a0World Health Organization classification of tumours of the nervous system","volume":"8","author":"Gonzales","year":"2001","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.annpat.2025.09.004_bib0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1750-3639.1993.tb00752.x","article-title":"The new WHO classification of brain tumours","volume":"3","author":"Kleihues","year":"1993","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0255","doi-asserted-by":"crossref","first-page":"vdae228","DOI":"10.1093\/noajnl\/vdae228","article-title":"cIMPACT-NOW update 9: recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics","volume":"7","author":"Aldape","year":"2025","journal-title":"Neuro-Oncol Adv"},{"key":"10.1016\/j.annpat.2025.09.004_bib0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/neuonc\/noae170","article-title":"cIMPACT-NOW Update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0265","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","article-title":"cIMPACT-NOW update 3: recommended diagnostic criteria for \u00ab\u00a0Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\u00a0\u00bb","volume":"136","author":"Brat","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0270","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00401-020-02127-9","article-title":"cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas","volume":"139","author":"Brat","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0275","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bpa.12866","article-title":"cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors","volume":"30","author":"Ellison","year":"2020","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-019-01987-0","article-title":"cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1\u00a0alterations or BRAFV600E mutation","volume":"137","author":"Ellison","year":"2019","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0285","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bpa.12832","article-title":"cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading","volume":"30","author":"Louis","year":"2020","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","article-title":"cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3\u00a0K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-018-1808-0","article-title":"cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC)","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0300","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-024-01739-6","article-title":"Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2\u00a0meningiomas","volume":"12","author":"Ehret","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.annpat.2025.09.004_bib0305","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bpa.12524","article-title":"Loss of SMARCE1\u00a0expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis","volume":"28","author":"Tauziede-Espariat","year":"2018","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0310","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00401-020-02247-2","article-title":"Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1","volume":"141","author":"Sievers","year":"2021","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0315","first-page":"535","article-title":"Germline and somatic BAP1\u00a0mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0320","first-page":"noaf105","article-title":"Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes","author":"Sievers","year":"2025","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-020-02161-7","article-title":"Frequent inactivating mutations of the PBAF complex gene PBRM1\u00a0in meningioma with papillary features","volume":"140","author":"Williams","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0330","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0335","doi-asserted-by":"crossref","first-page":"djv377","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2025.09.004_bib0340","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","article-title":"Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis","volume":"91","author":"Mirian","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annpat.2025.09.004_bib0345","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bpa.12892","article-title":"TERT promoter mutations in primary and secondary WHO grade III meningioma","volume":"31","author":"Maier","year":"2021","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0350","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/neuonc\/noab213","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0355","doi-asserted-by":"crossref","first-page":"e12773","DOI":"10.1111\/nan.12773","article-title":"Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma","volume":"48","author":"Mirian","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0360","doi-asserted-by":"crossref","first-page":"109228","DOI":"10.18632\/oncotarget.22650","article-title":"Intratumoral heterogeneity and TERT promoter mutations in progressive\/higher-grade meningiomas","volume":"8","author":"Juratli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.annpat.2025.09.004_bib0365","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/neuros\/nyy154","article-title":"TERT alterations in progressive treatment-resistant meningiomas","volume":"65","author":"Juratli","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.annpat.2025.09.004_bib0370","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ijc.11013","article-title":"Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1\u00a0and p73\u00a0expression in 271\u00a0meningiomas correlation with tumor grade and clinical outcome","volume":"104","author":"Korshunov","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.annpat.2025.09.004_bib0375","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","article-title":"A role for chromosome 9p21\u00a0deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0380","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-023-01690-y","article-title":"CDKN2A\/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data","volume":"11","author":"Wach","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.annpat.2025.09.004_bib0385","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostr\u00f6m","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0390","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","article-title":"CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas","volume":"140","author":"Sievers","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0395","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-023-02543-7","article-title":"Even heterozygous loss of CDKN2A\/B greatly accelerates recurrence in aggressive meningioma","volume":"145","author":"Khan","year":"2023","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0400","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00401-023-02544-6","article-title":"Loss of p16\u00a0expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas","volume":"145","author":"Tang","year":"2023","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0405","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.2009.186","article-title":"CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16\u00a0protein expression and poor survival","volume":"23","author":"Krasinskas","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0410","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.3390\/cancers15204978","article-title":"Deletions of CDKN2A and MTAP detected by copy-number variation array are associated with loss of p16\u00a0and MTAP protein in pleural mesothelioma","volume":"15","author":"Vrugt","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2025.09.004_bib0415","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.3390\/cancers16193299","article-title":"MTAP and p16\u00a0IHC as markers for CDKN2A\/B loss in meningiomas","volume":"16","author":"Ozkizilkaya","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2025.09.004_bib0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnen\/nlab127","article-title":"Correlation of MTAP immunohistochemistry With CDKN2A status assessed by fluorescence in situ hybridization and clinicopathological features in CNS WHO Grade 2\u00a0and 3\u00a0meningiomas: a single center cohort study","volume":"81","author":"Sasaki","year":"2022","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0425","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnen\/nlaf062","article-title":"A comparison of CDKN2A status in gliomas using different techniques: the loss of p16 as a surrogate marker","volume":"84","author":"Tauzi\u00e8de-Espariat","year":"2025","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0430","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0435","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00401-023-02642-5","article-title":"Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2\u00a0and 3\u00a0meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042","volume":"146","author":"Maas","year":"2023","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.annpat.2025.09.004_bib0440","doi-asserted-by":"crossref","first-page":"e13132","DOI":"10.1111\/bpa.13132","article-title":"Clinical implementation of integrated molecular-morphologic risk prediction for meningioma","volume":"33","author":"Hielscher","year":"2023","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.annpat.2025.09.004_bib0445","doi-asserted-by":"crossref","first-page":"e70018","DOI":"10.1111\/nan.70018","article-title":"Testing meningiomas with methylation arrays: insights and recommendations from a large single-centre study","volume":"51","author":"Ruiz","year":"2025","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.annpat.2025.09.004_bib0225","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCO.0000000000000687","article-title":"Molecular alterations in meningioma: prognostic and therapeutic perspectives","volume":"32","author":"Birzu","year":"2020","journal-title":"Curr Opin Oncol"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649825001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649825001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:43:06Z","timestamp":1766414586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649825001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0242649825001865"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2025.09.004","relation":{},"ISSN":["0242-6498"],"issn-type":[{"type":"print","value":"0242-6498"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9s dans le grading des m\u00e9ningiomes\u00a0: l\u2019exp\u00e9rience de l\u2019H\u00f4pital Sainte-Anne","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}